rs2231142
rs2231142 · 4 retained evidence mentions
Source-grounded findings
Supporting evidence
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| variant | rs2231142 | “METHODS: To investigate this, we examined ABCG2 34G/A (rs2231137) and 421C/A (rs2231142) genetic variations in 149 HIV-infected patients (116 without hepatotoxicity, 33 with ARV-induced hepatotoxicity) and 151 healthy controls through the PCR-restriction fragment length polymorphism (PCR-RFLP) technique.” | 0.90 | hgvs_regex_v1 |
| variant | rs2231142 | “The frequency of rs2231142 in ABCG2 among Asian subgroups: implications for personalized rosuvastatin dosing.” | 0.90 | hgvs_regex_v1 |
| variant | rs2231142 | “METHOD: ABCG2 C421A (rs2231142), ABCB1 C3435T (rs1045642), COX-2 T8473C (rs5275) and COX-2 G306C (rs5277) were genotyped 104 breast cancer patients and 90 healthy controls using a real-time PCR for breast cancer susceptibility.” | 0.90 | hgvs_regex_v1 |
| variant | rs2231142 | “We investigated associations between single-nucleotide polymorphism (SNP) of the ATP-binding cassette efflux transporter gene ABCG2 (rs2231142), BP, and arterial stiffness in RA patients treated with MTX.” | 0.90 | hgvs_regex_v1 |